Article Text

PDF
Featured correspondence
Comments on an acute myocardial infarction study
  1. Peter Bramlage1,
  2. Ulrich Tebbe2
  1. 1Institute for Cardiovascular Pharmacology and Epidemiology, Mahlow, Germany
  2. 2Klinikum Lippe GmbH, Fachbereich Herz-Kreislauf, Detmold, Germany
  1. Correspondence to Professor Dr Ulrich Tebbe, Klinikum Lippe GmbH, Fachbereich Herz-Kreislauf, Röntgenstrasse 18, 32756 Detmold, Germany; ulrich.tebbe{at}klinikum-lippe.de

Statistics from Altmetric.com

The Authors' reply: We would like to thank Dr Tormen for his kind appreciation of our work.1 We fully agree with the comments you made and would like to take the opportunity to further clarify some important aspects.

(1) Patients who had contraindications to any of the components of optical medical therapy (OMT), such as hypotension for β-blocker use, thrombocytopenia for antiplatelet use, etc, were excluded from this analysis.2 Further 1-year mortality …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles